|
Re: No news
|
2
|
Resverlogix Corp.
|
Sep 17, 2022 06:19AM
|
|
Report of exempt distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Sep 10, 2022 06:34AM
|
|
Re: At least apabetalone shows up in a table here...
|
3
|
Resverlogix Corp.
|
Sep 05, 2022 09:04AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 31, 2022 02:51PM
|
|
Re: Zacks BTI Valuation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2022 10:48AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
1
|
Resverlogix Corp.
|
Aug 30, 2022 02:27PM
|
|
Re: Zacks BTI Valuation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 29, 2022 09:49AM
|
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
2
|
Resverlogix Corp.
|
Aug 23, 2022 06:44AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 08:34AM
|
|
Re: Clinical trials site
|
3
|
Zenith Epigenetics
|
Aug 20, 2022 07:25AM
|
|
Re: Clinical trials site
|
5
|
Zenith Epigenetics
|
Aug 20, 2022 07:05AM
|
|
Re: Approval of First ‘Epigenetic’ Drug for a Solid Tumor: January 31, 2020
|
3
|
Resverlogix Corp.
|
Aug 19, 2022 11:25AM
|
|
Re: Kausik Ray tweeted this this morning
|
7
|
Resverlogix Corp.
|
Aug 18, 2022 07:37AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
2
|
Resverlogix Corp.
|
Aug 16, 2022 07:16AM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 15, 2022 01:19PM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 13, 2022 01:28PM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 13, 2022 11:18AM
|
|
Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 13, 2022 08:49AM
|
|
Re: Also interesting, but less encouraging
|
1
|
Resverlogix Corp.
|
Aug 06, 2022 10:41AM
|
|
Re: Also interesting, but less encouraging
|
4
|
Resverlogix Corp.
|
Aug 05, 2022 12:16PM
|
